Mayne Pharma Group Ltd
F:HG6
Mayne Pharma Group Ltd
F:HG6
Price:
1.29
EUR
-5.15%
Market Closed
Market Cap:
€109.7m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
M
|
Mayne Pharma Group Ltd
F:HG6
|
AU |
|
C
|
CVS Group PLC
F:4C9
|
UK |
|
Nidec Corp
F:NIB1
|
JP |
Price Target
Loading...
Revenue
Loading...
Gross Profit
Loading...
Operating Income
Loading...
Pre-Tax Income
Loading...
Net Income
Loading...
Wall St Price Targets
HG6 Price Targets Summary
Mayne Pharma Group Ltd
Mayne Pharma Group Ltd
Wall Street analysts forecast HG6 stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for HG6 is 8.61 EUR with a low forecast of 8.53 EUR and a high forecast of 8.86 EUR.
Lowest Forecast
Price Target
8.53
EUR
561% Upside
Average Forecast
Price Target
8.61
EUR
568% Upside
Highest Forecast
Price Target
8.86
EUR
587% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is HG6's stock price target?
Price Target
8.61
EUR
8.61
EUR
According to Wall Street analysts, the average 1-year price target for HG6 is 8.61 EUR with a low forecast of 8.53 EUR and a high forecast of 8.86 EUR.
What is the Revenue forecast for Mayne Pharma Group Ltd?
Projected CAGR
1%
1%
Over the last 7 years, the compound annual growth rate for Revenue has been -4%. The projected CAGR for the next 3 years is 1%.
